FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Original Application (Asegua Therapeutics LLC)

View source ↗

Summary

FDA approved Ledipasvir and Sofosbuvir under an Original Application filed by Asegua Therapeutics LLC for the treatment of hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

ORIG AP for LEDIPASVIR AND SOFOSBUVIR (LEDIPASVIR AND SOFOSBUVIR)